Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review

[1]  M. Brainin,et al.  Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations 2012 , 2004, European journal of neurology.

[2]  A. Albanese,et al.  Motor features and response to oral levodopa in patients with Parkinson’s disease under continuous dopaminergic infusion or deep brain stimulation , 2012, European journal of neurology.

[3]  M. Lanotte,et al.  Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[4]  Angelo Antonini,et al.  A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation , 2011, Journal of Neurology.

[5]  Chris J Hass,et al.  A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohort. , 2010, Journal of neurosurgery.

[6]  Anette Schrag,et al.  What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? , 2010, Movement disorders : official journal of the Movement Disorder Society.

[7]  Grant D. Huang,et al.  Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. , 2010, The New England journal of medicine.

[8]  Keith Wheatley,et al.  Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial , 2010, The Lancet Neurology.

[9]  Y. Agid,et al.  Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[10]  D. Bowers,et al.  Cognitive Declines After Unilateral Deep Brain Stimulation Surgery in Parkinson's Disease: A Controlled Study Using Reliable Change, Part II , 2010, The Clinical neuropsychologist.

[11]  T. van Laar,et al.  Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations. , 2010, Parkinsonism & related disorders.

[12]  J. Lökk.  Reduced life-space of non-professional caregivers to Parkinson's disease patients with increased disease duration , 2009, Clinical Neurology and Neurosurgery.

[13]  I. Forgacs,et al.  Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life , 2009, Movement disorders : official journal of the Movement Disorder Society.

[14]  Y. Agid,et al.  Long‐term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[15]  D. Devos.  Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[16]  D. Bowers,et al.  Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: The COMPARE Trial , 2009, Annals of neurology.

[17]  R. D. de Haan,et al.  Cognitive decline in Parkinson’s disease: A prospective longitudinal study , 2009, Journal of the International Neuropsychological Society.

[18]  D. Bowers,et al.  Cognitive declines one year after unilateral deep brain stimulation surgery in parkinson's disease: A controlled study using reliable change , 2009, The Clinical neuropsychologist.

[19]  Grant D. Huang,et al.  Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. , 2009, JAMA.

[20]  P. A. House,et al.  Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease: A Randomized Controlled Trial , 2009 .

[21]  C. Bungener,et al.  What relation is there between deep brain stimulation and coping strategies in Parkinson's disease? , 2008, Movement disorders : official journal of the Movement Disorder Society.

[22]  Adrian Danek,et al.  Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study , 2008, The Lancet Neurology.

[23]  Pablo Mir,et al.  Efficacy of long‐term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study , 2008, Movement disorders : official journal of the Movement Disorder Society.

[24]  Lihong Li,et al.  Effects of Bilateral Deep Brain Stimulation of the Subthalamic Nucleus on Olfactory Function in Parkinson’s Disease Patients , 2008, Stereotactic and Functional Neurosurgery.

[25]  W. Oertel,et al.  Continuous Jejunal Levodopa Infusion in Patients With Advanced Parkinson Disease: Practical Aspects and Outcome of Motor and Non-motor Complications , 2008, Clinical neuropharmacology.

[26]  A. Benabid,et al.  Effects of subthalamic nucleus stimulation and levodopa on freezing of gait in Parkinson disease , 2008, Neurology.

[27]  G. Deuschl,et al.  Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism , 2008, Neurology.

[28]  M. Canesi,et al.  Duodenal Levodopa Infusion Improves Quality of Life in Advanced Parkinson’s Disease , 2008, Neurodegenerative Diseases.

[29]  T. Lewander,et al.  Enteral Levodopa/Carbidopa Infusion in Advanced Parkinson Disease: Long-term Exposure , 2008, Clinical neuropharmacology.

[30]  N. Tandon.  Neurosurgery at an earlier stage of Parkinson disease: A randomized, controlled trial , 2008 .

[31]  Francesc Valldeoriola,et al.  Prospective comparative study on cost‐effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[32]  Sheng-Huang Lin,et al.  NEUROPSYCHOLOGICAL EFFECTS AFTER CHRONIC SUBTHALAMIC STIMULATION AND THE TOPOGRAPHY OF THE NUCLEUS IN PARKINSON'S DISEASE , 2007, Neurosurgery.

[33]  J. Jankovic,et al.  Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson’s disease , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[34]  J. Mink,et al.  SAFETY AND EFFICACY OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION PERFORMED WITH LIMITED INTRAOPERATIVE MAPPING FOR TREATMENT OF PARKINSON'S DISEASE , 2007, Neurosurgery.

[35]  P. Kempster,et al.  Patterns of levodopa response in Parkinson's disease: a clinico-pathological study. , 2007, Brain : a journal of neurology.

[36]  G. Deuschl,et al.  Thirty days complication rate following surgery performed for deep‐brain‐stimulation , 2007, Movement disorders : official journal of the Movement Disorder Society.

[37]  Ioannis U Isaias,et al.  Brain networks underlining verbal fluency decline during STN-DBS in Parkinson's disease: an ECD-SPECT study. , 2007, Parkinsonism & related disorders.

[38]  J. Dostrovsky,et al.  Levodopa response in long‐term bilateral subthalamic stimulation for Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[39]  B. Bejjani,et al.  Neurosurgery in Parkinson disease: A distressed mind in a repaired body? , 2007, Neurology.

[40]  K. Lyons,et al.  Subthalamic Nucleus Stimulation in Parkinson’s Disease Patients Intolerant to Levodopa , 2007, Stereotactic and Functional Neurosurgery.

[41]  S. Papapetropoulos.  Neuropsychological effects of bilateral STN stimulation in Parkinson disease: A controlled studySmeding HMM, Speelman JD, Koning-Haanstra M, et al (Univ of Amsterdam; Univ Med Ctr Groningen, The Netherlands; Saint Elisabeth Hosp Tilburg, The Netherlands) Neurology 66:1830–1836, 2006§ , 2007 .

[42]  L. Regeur,et al.  Dopamine transporter imaging and the effects of deep brain stimulation in patients with Parkinson’s disease , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[43]  G. Deuschl,et al.  A randomized trial of deep-brain stimulation for Parkinson's disease. , 2006, The New England journal of medicine.

[44]  J. Nutt.  Long-term 24-hour duodenal infusion of levodopa: Outcome and dose requirements , 2006, Neurology.

[45]  K. Østergaard,et al.  Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus , 2006, Movement disorders : official journal of the Movement Disorder Society.

[46]  C. Mariani,et al.  Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson’s disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[47]  B Bioulac,et al.  Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[48]  D. Deleu,et al.  Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements. , 2006, Neurology.

[49]  W. Fogel,et al.  Gait analysis in patients with advanced Parkinson disease: different or additive effects on gait induced by levodopa and chronic STN stimulation , 2006, Journal of Neural Transmission.

[50]  M. Scerrati,et al.  Functional improvement after subthalamic stimulation in Parkinson’s disease: a non-equivalent controlled study with 12–24 month follow up , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[51]  S. Rehncrona,et al.  Deep‐brain stimulation in the subthalamic nuclei improves balance performance in patients with Parkinson's disease, when tested without anti‐parkinsonian medication , 2005, Acta neurologica Scandinavica.

[52]  V. Visser-Vandewalle,et al.  Long-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: a four year follow-up study. , 2005, Parkinsonism & related disorders.

[53]  P. Hogarth,et al.  Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. , 2005, Archives of neurology.

[54]  Laurent Gerbaud,et al.  Impact of the motor complications of Parkinson's disease on the quality of life , 2005, Movement disorders : official journal of the Movement Disorder Society.

[55]  Andrew Evans,et al.  Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challenges , 2005, Movement disorders : official journal of the Movement Disorder Society.

[56]  D. Nyholm,et al.  Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease , 2005, Neurology.

[57]  Dd Amsterdam.  Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: A comparison of neuropsychological effects , 2005 .

[58]  M. Brainin,et al.  Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations 2004 * , 2004, European journal of neurology.

[59]  E. Tolosa,et al.  Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[60]  J. Villemure,et al.  Absence of cholinergic deficits in “pure” vascular dementia , 2005, Neurology.

[61]  S. Fox,et al.  A 10 year retrospective audit of long-term apomorphine use in Parkinson’s disease , 2004, Journal of Neurology.

[62]  J. Obeso,et al.  Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson’s disease 4 years after surgery: double blind and open label evaluation , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[63]  Matthew B. Stern,et al.  Bilateral Stimulation of the Subthalamic Nucleus in Parkinson’s Disease: Surgical Efficacy and Prediction of Outcome , 2004, Stereotactic and Functional Neurosurgery.

[64]  J. Villemure,et al.  l-Dopa-induced dyskinesia improvement after STN-DBS depends upon medication reduction , 2004, Neurology.

[65]  R. D. de Haan,et al.  Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD , 2004, Neurology.

[66]  R. Marconi,et al.  Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: a follow-up of two years. , 2004, Archives of gerontology and geriatrics. Supplement.

[67]  S. Calne.  The Psychosocial Impact of Late‐Stage Parkinson's Disease , 2003, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[68]  A. Benabid.  Deep brain stimulation for Parkinson’s disease , 2003, Current Opinion in Neurobiology.

[69]  A. Benabid,et al.  Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 2003, The New England journal of medicine.

[70]  A. Antonini,et al.  Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson’s disease , 2003, Neurological Sciences.

[71]  J. Kulisevsky,et al.  Effects of pallidotomy and bilateral subthalamic stimulation on cognitive function in Parkinson disease , 2003, Journal of Neurology.

[72]  H. Lennernäs,et al.  Optimizing Levodopa Pharmacokinetics: Intestinal Infusion Versus Oral Sustained-Release Tablets , 2003, Clinical neuropharmacology.

[73]  A. Priori,et al.  Deep brain stimulation for Parkinson's disease: the experience of the Policlinico-San Paolo Group in Milan , 2003, Neurological Sciences.

[74]  Andrew J Lees,et al.  Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long‐term follow‐up study of 64 patients , 2002, Movement disorders : official journal of the Movement Disorder Society.

[75]  R. Iansek,et al.  Deep brain stimulation of the subthalamic nucleus in Parkinson's disease , 2002, The Medical journal of Australia.

[76]  Niels Sunde,et al.  Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations , 2002, Movement disorders : official journal of the Movement Disorder Society.

[77]  K. Ostergaard,et al.  Health‐Related quality of life in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nuclei , 2002, Movement disorders : official journal of the Movement Disorder Society.

[78]  G. Baltuch,et al.  Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety. , 2002, Journal of neurosurgery.

[79]  Y. Agid,et al.  Clinical predictive factors of subthalamic stimulation in Parkinson's disease. , 2002, Brain : a journal of neurology.

[80]  D. Nyholm,et al.  Duodenal levodopa infusion in Parkinson's disease – long‐term experience , 2001, Acta neurologica Scandinavica.

[81]  Lorys Castelli,et al.  Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: comparison of pre- and postoperative neuropsychological evaluation , 2001, Journal of the Neurological Sciences.

[82]  P. Krack,et al.  Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. , 2001, The New England journal of medicine.

[83]  L. Vacca,et al.  Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results , 2001, Neurological Sciences.

[84]  S. T. G. Roup,et al.  DEEP-BRAIN STIMULATION OF THE SUBTHALAMIC NUCLEUS OR THE PARS INTERNA OF THE GLOBUS PALLIDUS IN PARKINSON'S DISEASE , 2001 .

[85]  A L Benabid,et al.  Neuropsychological changes between “off” and “on” STN or GPi stimulation in Parkinson’s disease , 2000, Neurology.

[86]  Y Agid,et al.  Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. , 2000, Archives of neurology.

[87]  P. Odin,et al.  Subcutaneous apomorphine in late stage Parkinson’s disease: a long term follow up , 1998, Journal of neurology, neurosurgery, and psychiatry.

[88]  A J Lees,et al.  Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson’s disease , 1998, Journal of neurology, neurosurgery, and psychiatry.

[89]  M. Mark,et al.  Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.

[90]  P. Leigh,et al.  Use of apomorphine in parkinsonian patients with neuropsychiatric complications to oral treatment. , 1997, Parkinsonism & related disorders.

[91]  A. Hughes,et al.  Subcutaneous apomorphine in parkinson's disease: Response to chronic administration for up to five years , 1993, Movement disorders : official journal of the Movement Disorder Society.

[92]  H. S. Davis,et al.  A Controlled Study , 1966 .